Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722994 · ClinicalTrials.gov registry record · Phase 4
A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites
A Phase 4 study, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 97
- Enrollment target
NCT01722994 is a Phase 4 study that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 97 participants.
The verdict
NCT01722994, a Phase 4 study, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 97 participants
- Enrollment target
Study Summary
Some Dermatologists prefer absorbable suture to non-absorbable suture in the closure of punch biopsy sites. The reason these are often preferred is because patients do not have to pay for another visit to get the suture material removed. Also patients are not inconvenienced into returning to the office for suture removal1. However, the absorbable suture material currently used by most Dermatologists is very expensive. In order to evaluate ways to reduce costs for patients, we will compare a less expensive suture material (chromic gut) with one of the absorbable suture materials currently used in clinical practice (PDS). Patients who are eligible and choose to participate in the study will undergo a punch biopsy and a suture will be used to close the skin. The type of suture received by the patient will be randomized, like the flip of a coin. Group A will receive PDS and Group B will receive chromic gut suture. After one weeks time, the patient will return to clinic and their dermatologist will evaluate the biopsy site for redness, wound infection, wound opening, and scar formation. The patients will be given a questionnaire evaluating their satisfaction with the cosmetic outcome and any pain caused by the suture materials. If the suture came out before the visit, the patient will be asked to report on what day the suture fell out. The patients will return two more times over the next two weeks to receive the same questionnaire and evaluation by their dermatologist.
Interventions
- DEVICE Polyglactin 910 sterile synthetic absorbable suture (Ethicon)
- DEVICE Chromic Gut Sterile absorbable Suture (Ethicon)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 97 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01722994
The ClinicalTrials.gov registry entry for NCT01722994 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 97 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Polyglactin 910 sterile synthetic absorbable suture (Ethicon) is the first listed.
NCT01722994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01722994 about?
NCT01722994 is a clinical study titled "A Comparison of Polyglactin 910 and Chromic Gut Suture in the Closure of Punch Biopsy Sites". Some Dermatologists prefer absorbable suture to non-absorbable suture in the closure of punch biopsy sites. The reason these are often preferred is because patients do not have to pay for another visit to get the suture material removed. Also patients are not inconvenienced into returning to the off...
What is the current status of trial NCT01722994?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 97 participants. The study started on 2012-08. Estimated completion is 2014-09.
What interventions are being tested in trial NCT01722994?
The interventions under investigation include: Polyglactin 910 sterile synthetic absorbable suture (Ethicon) (DEVICE), Chromic Gut Sterile absorbable Suture (Ethicon) (DEVICE).
Who is sponsoring clinical trial NCT01722994?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.